Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Jun;77(12):2162–2170. doi: 10.1038/bjc.1998.361

Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.

S Yi 1, J R Chen 1, J Viallet 1, R H Schwall 1, T Nakamura 1, M S Tsao 1
PMCID: PMC2150402  PMID: 9649128

Abstract

We have studied the mitogenic, motogenic and morphogenic effects of hepatocyte growth factor (HGF), also known as scatter factor (SF), on 15 non-small-cell lung carcinoma (NSCLC) cell lines that have had their ras genotype determined. HGF/SF stimulated proliferation in only three cell lines and exerted no mitogenic activity on six lines. The growth of the remaining six lines was inhibited. The mitogenic effects were not related to the ras genotype of these cell lines, but the inhibitory effect was more commonly observed in cell lines with relatively high levels of Met/HGF receptor (HGFR) expression. HGF/SF induced or enhanced both scatter activity on monolayer culture and single-cell invasion in collagen gels in approximately half of these cell lines. Although the ras genotype of tumour cells did not influence the HGF/SF-induced motogenic activity, cell lines with the mutant ras genotype more commonly demonstrated a spontaneous motogenic activity than those with the wild-type ras genotype. When tumour cells were grown in collagen gels, HGF/SF induced irregular branching extensions of cell aggregates formed by five out of eight adenocarcinoma cell lines, but significant lumen morphogenesis was distinctly absent. The presence of autocrine HGF/SF loop in these tumour cell lines did not influence their spontaneous or HGF/SF-induced mitogenic, motogenic or morphogenic activities. Overall, our data suggest that stimulation of cell motility, rather than proliferation or differentiation, is the predominant paracrine effect of HGF/SF on NSCLC cells in vitro.

Full text

PDF
2162

Images in this article

2164Figure 1
on p.2164
2164Figure 2
on p.2164
2166Figure 4
on p.2166
2167Figure 5
on p.2167
2168Figure 6
on p.2168

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bottaro D. P., Rubin J. S., Faletto D. L., Chan A. M., Kmiecik T. E., Vande Woude G. F., Aaronson S. A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991 Feb 15;251(4995):802–804. doi: 10.1126/science.1846706. [DOI] [PubMed] [Google Scholar]
  2. Brinkmann V., Foroutan H., Sachs M., Weidner K. M., Birchmeier W. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol. 1995 Dec;131(6 Pt 1):1573–1586. doi: 10.1083/jcb.131.6.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bussolino F., Di Renzo M. F., Ziche M., Bocchietto E., Olivero M., Naldini L., Gaudino G., Tamagnone L., Coffer A., Comoglio P. M. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol. 1992 Nov;119(3):629–641. doi: 10.1083/jcb.119.3.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Di Renzo M. F., Narsimhan R. P., Olivero M., Bretti S., Giordano S., Medico E., Gaglia P., Zara P., Comoglio P. M. Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene. 1991 Nov;6(11):1997–2003. [PubMed] [Google Scholar]
  5. Fournier T. M., Kamikura D., Teng K., Park M. Branching tubulogenesis but not scatter of madin-darby canine kidney cells requires a functional Grb2 binding site in the Met receptor tyrosine kinase. J Biol Chem. 1996 Sep 6;271(36):22211–22217. doi: 10.1074/jbc.271.36.22211. [DOI] [PubMed] [Google Scholar]
  6. Gazdar A. F., Oie H. K. Re: Growth of cell lines and clinical specimens of human non-small cell lung cancer in a serum-free defined medium. Cancer Res. 1986 Nov;46(11):6011–6012. [PubMed] [Google Scholar]
  7. Grant D. S., Kleinman H. K., Goldberg I. D., Bhargava M. M., Nickoloff B. J., Kinsella J. L., Polverini P., Rosen E. M. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1937–1941. doi: 10.1073/pnas.90.5.1937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Graziani A., Gramaglia D., Cantley L. C., Comoglio P. M. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. J Biol Chem. 1991 Nov 25;266(33):22087–22090. [PubMed] [Google Scholar]
  9. Graziani A., Gramaglia D., dalla Zonca P., Comoglio P. M. Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. J Biol Chem. 1993 May 5;268(13):9165–9168. [PubMed] [Google Scholar]
  10. Halaban R., Rubin J. S., Funasaka Y., Cobb M., Boulton T., Faletto D., Rosen E., Chan A., Yoko K., White W. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene. 1992 Nov;7(11):2195–2206. [PubMed] [Google Scholar]
  11. Harvey P., Warn A., Newman P., Perry L. J., Ball R. Y., Warn R. M. Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas. J Pathol. 1996 Dec;180(4):389–394. doi: 10.1002/(SICI)1096-9896(199612)180:4<389::AID-PATH685>3.0.CO;2-K. [DOI] [PubMed] [Google Scholar]
  12. Jeffers M., Rao M. S., Rulong S., Reddy J. K., Subbarao V., Hudson E., Vande Woude G. F., Resau J. H. Hepatocyte growth factor/scatter factor-Met signaling induces proliferation, migration, and morphogenesis of pancreatic oval cells. Cell Growth Differ. 1996 Dec;7(12):1805–1813. [PubMed] [Google Scholar]
  13. Johnson M., Koukoulis G., Matsumoto K., Nakamura T., Iyer A. Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. Hepatology. 1993 Jun;17(6):1052–1061. [PubMed] [Google Scholar]
  14. Kan M., Zhang G. H., Zarnegar R., Michalopoulos G., Myoken Y., McKeehan W. L., Stevens J. I. Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. Biochem Biophys Res Commun. 1991 Jan 15;174(1):331–337. doi: 10.1016/0006-291x(91)90524-b. [DOI] [PubMed] [Google Scholar]
  15. Longati P., Bardelli A., Ponzetto C., Naldini L., Comoglio P. M. Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene. 1994 Jan;9(1):49–57. [PubMed] [Google Scholar]
  16. Matsumoto K., Hashimoto K., Yoshikawa K., Nakamura T. Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res. 1991 Sep;196(1):114–120. doi: 10.1016/0014-4827(91)90462-4. [DOI] [PubMed] [Google Scholar]
  17. Matsumoto K., Matsumoto K., Nakamura T., Kramer R. H. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem. 1994 Dec 16;269(50):31807–31813. [PubMed] [Google Scholar]
  18. Matsumoto K., Nakamura T. Emerging multipotent aspects of hepatocyte growth factor. J Biochem. 1996 Apr;119(4):591–600. doi: 10.1093/oxfordjournals.jbchem.a021283. [DOI] [PubMed] [Google Scholar]
  19. Miyazawa K., Shimomura T., Kitamura A., Kondo J., Morimoto Y., Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem. 1993 May 15;268(14):10024–10028. [PubMed] [Google Scholar]
  20. Montesano R., Schaller G., Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell. 1991 Aug 23;66(4):697–711. doi: 10.1016/0092-8674(91)90115-f. [DOI] [PubMed] [Google Scholar]
  21. Nagamine K., Shibamoto S., Takeuchi K., Miyazawa K., Kitamura N., Chatani Y., Kohno M., Ito F. Dissociation of c-fos induction and mitogen-activated-protein kinase activation from the hepatocyte-growth-factor-induced motility response in human gastric carcinoma cells. Eur J Biochem. 1996 Mar 1;236(2):476–481. doi: 10.1111/j.1432-1033.1996.t01-1-00476.x. [DOI] [PubMed] [Google Scholar]
  22. Nakamura T., Nawa K., Ichihara A., Kaise N., Nishino T. Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett. 1987 Nov 30;224(2):311–316. doi: 10.1016/0014-5793(87)80475-1. [DOI] [PubMed] [Google Scholar]
  23. Naldini L., Tamagnone L., Vigna E., Sachs M., Hartmann G., Birchmeier W., Daikuhara Y., Tsubouchi H., Blasi F., Comoglio P. M. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. EMBO J. 1992 Dec;11(13):4825–4833. doi: 10.1002/j.1460-2075.1992.tb05588.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Niranjan B., Buluwela L., Yant J., Perusinghe N., Atherton A., Phippard D., Dale T., Gusterson B., Kamalati T. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development. 1995 Sep;121(9):2897–2908. doi: 10.1242/dev.121.9.2897. [DOI] [PubMed] [Google Scholar]
  25. Okano Y., Mizuno K., Osada S., Nakamura T., Nozawa Y. Tyrosine phosphorylation of phospholipase C gamma in c-met/HGF receptor-stimulated hepatocytes: comparison with HepG2 hepatocarcinoma cells. Biochem Biophys Res Commun. 1993 Feb 15;190(3):842–848. doi: 10.1006/bbrc.1993.1125. [DOI] [PubMed] [Google Scholar]
  26. Olivero M., Rizzo M., Madeddu R., Casadio C., Pennacchietti S., Nicotra M. R., Prat M., Maggi G., Arena N., Natali P. G. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. Br J Cancer. 1996 Dec;74(12):1862–1868. doi: 10.1038/bjc.1996.646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Osterop A. P., Medema R. H., Ouwens D. M., Van der Zon G. C., Möller W., Maassen J. A. Activation of overexpressed receptors for insulin and epidermal growth factor interferes in mitogenic signaling without affecting the activation of p21ras. Biochemistry. 1994 Jun 14;33(23):7453–7459. doi: 10.1021/bi00189a053. [DOI] [PubMed] [Google Scholar]
  28. Park M., Dean M., Cooper C. S., Schmidt M., O'Brien S. J., Blair D. G., Vande Woude G. F. Mechanism of met oncogene activation. Cell. 1986 Jun 20;45(6):895–904. doi: 10.1016/0092-8674(86)90564-7. [DOI] [PubMed] [Google Scholar]
  29. Pelicci G., Giordano S., Zhen Z., Salcini A. E., Lanfrancone L., Bardelli A., Panayotou G., Waterfield M. D., Ponzetto C., Pelicci P. G. The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene. 1995 Apr 20;10(8):1631–1638. [PubMed] [Google Scholar]
  30. Phelps R. M., Johnson B. E., Ihde D. C., Gazdar A. F., Carbone D. P., McClintock P. R., Linnoila R. I., Matthews M. J., Bunn P. A., Jr, Carney D. NCI-Navy Medical Oncology Branch cell line data base. J Cell Biochem Suppl. 1996;24:32–91. doi: 10.1002/jcb.240630505. [DOI] [PubMed] [Google Scholar]
  31. Ponzetto C., Bardelli A., Zhen Z., Maina F., dalla Zonca P., Giordano S., Graziani A., Panayotou G., Comoglio P. M. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell. 1994 Apr 22;77(2):261–271. doi: 10.1016/0092-8674(94)90318-2. [DOI] [PubMed] [Google Scholar]
  32. Ponzetto C., Zhen Z., Audero E., Maina F., Bardelli A., Basile M. L., Giordano S., Narsimhan R., Comoglio P. Specific uncoupling of GRB2 from the Met receptor. Differential effects on transformation and motility. J Biol Chem. 1996 Jun 14;271(24):14119–14123. doi: 10.1074/jbc.271.24.14119. [DOI] [PubMed] [Google Scholar]
  33. Rodenhuis S., Slebos R. J. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 1992 May 1;52(9 Suppl):2665s–2669s. [PubMed] [Google Scholar]
  34. Rosen E. M., Nigam S. K., Goldberg I. D. Scatter factor and the c-met receptor: a paradigm for mesenchymal/epithelial interaction. J Cell Biol. 1994 Dec;127(6 Pt 2):1783–1787. doi: 10.1083/jcb.127.6.1783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Royal I., Park M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J Biol Chem. 1995 Nov 17;270(46):27780–27787. doi: 10.1074/jbc.270.46.27780. [DOI] [PubMed] [Google Scholar]
  36. Rygaard K., Nakamura T., Spang-Thomsen M. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer. 1993 Jan;67(1):37–46. doi: 10.1038/bjc.1993.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shiota G., Rhoads D. B., Wang T. C., Nakamura T., Schmidt E. V. Hepatocyte growth factor inhibits growth of hepatocellular carcinoma cells. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):373–377. doi: 10.1073/pnas.89.1.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Siegfried J. M., Weissfeld L. A., Singh-Kaw P., Weyant R. J., Testa J. R., Landreneau R. J. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer. Cancer Res. 1997 Feb 1;57(3):433–439. [PubMed] [Google Scholar]
  39. Singh-Kaw P., Zarnegar R., Siegfried J. M. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human bronchial epithelial cells. Am J Physiol. 1995 Jun;268(6 Pt 1):L1012–L1020. doi: 10.1152/ajplung.1995.268.6.L1012. [DOI] [PubMed] [Google Scholar]
  40. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 1987 May 21;327(6119):239–242. doi: 10.1038/327239a0. [DOI] [PubMed] [Google Scholar]
  41. Strain A. J., Wallace L., Joplin R., Daikuhara Y., Ishii T., Kelly D. A., Neuberger J. M. Characterization of biliary epithelial cells isolated from needle biopsies of human liver in the presence of hepatocyte growth factor. Am J Pathol. 1995 Feb;146(2):537–545. [PMC free article] [PubMed] [Google Scholar]
  42. Sugio K., Ishida T., Yokoyama H., Inoue T., Sugimachi K., Sasazuki T. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res. 1992 May 15;52(10):2903–2906. [PubMed] [Google Scholar]
  43. Tajima H., Matsumoto K., Nakamura T. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res. 1992 Oct;202(2):423–431. doi: 10.1016/0014-4827(92)90095-p. [DOI] [PubMed] [Google Scholar]
  44. Takanami I., Tanana F., Hashizume T., Kikuchi K., Yamamoto Y., Yamamoto T., Kodaira S. Hepatocyte growth factor and c-Met/hepatocyte growth factor receptor in pulmonary adenocarcinomas: an evaluation of their expression as prognostic markers. Oncology. 1996 Sep-Oct;53(5):392–397. doi: 10.1159/000227594. [DOI] [PubMed] [Google Scholar]
  45. Tannapfel A., Yasui W., Yokozaki H., Wittekind C., Tahara E. Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines. Virchows Arch. 1994;425(2):139–144. doi: 10.1007/BF00230350. [DOI] [PubMed] [Google Scholar]
  46. Tsao M. S., Zhu H., Giaid A., Viallet J., Nakamura T., Park M. Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth Differ. 1993 Jul;4(7):571–579. [PubMed] [Google Scholar]
  47. Weidner K. M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J Cell Biol. 1990 Nov;111(5 Pt 1):2097–2108. doi: 10.1083/jcb.111.5.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Yoshinaga Y., Fujita S., Gotoh M., Nakamura T., Kikuchi M., Hirohashi S. Human lung cancer cell line producing hepatocyte growth factor/scatter factor. Jpn J Cancer Res. 1992 Dec;83(12):1257–1261. doi: 10.1111/j.1349-7006.1992.tb02755.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Zhu H., Naujokas M. A., Fixman E. D., Torossian K., Park M. Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis. J Biol Chem. 1994 Nov 25;269(47):29943–29948. [PubMed] [Google Scholar]
  50. Zhu H., Naujokas M. A., Park M. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor. Cell Growth Differ. 1994 Apr;5(4):359–366. [PubMed] [Google Scholar]
  51. Zioncheck T. F., Richardson L., Liu J., Chang L., King K. L., Bennett G. L., Fügedi P., Chamow S. M., Schwall R. H., Stack R. J. Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. J Biol Chem. 1995 Jul 14;270(28):16871–16878. doi: 10.1074/jbc.270.28.16871. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES